LRP5 and osteoporosis-pseudoglioma syndrome: Recessive loss-of-function mutations that map to the Human LRP5 gene cause osteoporosis pseudoglioma (OPPG) syndrome, which is characterized by low bone mass, while a dominant gain-of-function mutation results in the High Bone Mass (HBM) trait [6]–[12].